Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treating cancer with self-driving chimeric antigen receptors

Compositions and methods for treating cancer with self-driving chimeric antigen receptors

US Patent 11969443 · Granted Apr 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor therapies for treating solid tumors2025
Compositions and methods for treating cancer with anti-BCMA immunotherapy2025
Compositions and methods for treating cancer with anti-BCMA immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy2025
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy2025
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy2025
Compositions and methods for treating cancer with DuoCARs2025
Compositions and methods for treating cancer with DuoCARs2025
Method to treat cancer with engineered T-cells2025
Method to treat cancer with engineered T-cells2025
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy2024